Esperion Therapeutics (ESPR)
(Delayed Data from NSDQ)
$2.19 USD
+0.10 (4.78%)
Updated May 10, 2024 04:00 PM ET
After-Market: $2.19 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | 0.34 |
Last EPS Surprise | 525.00% |
ABR | 1.88 |
Earnings ESP
|
19.30% |
---|---|
Current Year | -0.38 |
Next Year | 0.40 |
EPS (TTM) | -0.99 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 45.05M | 67.42M | 280.77M | 495.95M |
# of Estimates | 5 | 5 | 5 | 4 |
High Estimate | 60.00M | 91.20M | 323.30M | 710.20M |
Low Estimate | 37.80M | 46.75M | 180.23M | 371.91M |
Year ago Sales | 25.79M | 33.97M | 116.33M | 280.77M |
Year over Year Growth Est. | 74.66% | 98.46% | 141.35% | 76.64% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.12 | -0.38 | 0.40 |
# of Estimates | 6 | 5 | 5 | 5 |
Most Recent Consensus | -0.23 | -0.18 | -0.80 | 0.02 |
High Estimate | -0.10 | -0.05 | -0.02 | 1.49 |
Low Estimate | -0.25 | -0.20 | -0.95 | -0.12 |
Year ago EPS | -0.46 | -0.37 | -2.03 | -0.38 |
Year over Year Growth Est. | 58.70% | 67.57% | 81.28% | 205.79% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 2 | 2 | 2 |
Up Last 30 Days | 1 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 4 | 3 | 2 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 1 |
Down Last 60 Days | 2 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.12 | -0.38 | 0.40 |
7 Days Ago | -0.23 | -0.15 | -0.68 | 0.30 |
30 Days Ago | -0.23 | -0.15 | -0.68 | 0.31 |
60 Days Ago | -0.01 | -0.19 | -0.66 | 0.33 |
90 Days Ago | 0.13 | -0.21 | -0.13 | 0.67 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.15 | -0.13 | -0.10 | 0.14 |
Zacks Consensus Estimate | -0.19 | -0.12 | -0.38 | 0.40 |
Earnings ESP | 19.30% | -7.76% | 73.96% | -65.66% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.34 | -0.50 | -0.37 | -0.46 | NA |
Estimate | -0.08 | -0.53 | -0.42 | -0.63 | NA |
Difference | 0.42 | 0.03 | 0.05 | 0.17 | 0.17 |
Surprise | 525.00% | 5.66% | 11.90% | 26.98% | 142.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more